Sales and Marketing

Showing 15 posts of 11524 posts found.

15813-a-senior-woman-receiving-a-vaccination-shot-from-her-doctor-pv

Influenza vaccine market to grow to £4.3 billion by 2025

October 31, 2016 Sales and Marketing influenza

GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion …

FDA rejects Sarilumab due to production facility issues

October 31, 2016 Manufacturing and Production, Sales and Marketing FDA, Regeneron, Sanofi, sarilumab

The US Food and Drugs administration has decided to reject the application for Sarilumab, Regeneron and Sanofi’s rheumatoid arthritis treatment, …
teva_copy

Teva sets out to delay generic competitor to Copaxone

October 31, 2016 Sales and Marketing Copaxone, Teva, Teva Pharmaceutical, generics

Teva Pharmacetuical, the Israel-based pharmaceutical company, submitted a document to the FDA on 30 October; the document outlines the differences …
astellas_tokyo_copy

Astellas snatches up oncology firm Ganymed for $1.4 billion

October 31, 2016 Research and Development, Sales and Marketing Astellas, Ganymed, IMAB362

Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …
astrazeneca_logo_building

AstraZeneca’s head and neck cancer treatment clinical trials put on hold

October 31, 2016 Sales and Marketing AstraZeneca, clinical hold, clinical trials, immunotherapy, phase III

AstraZeneca, the Cambridge-based British company, had recruitment for its final stage Phase III trials placed on partial hold. The drug …
cynthia_chiaramitara

Novartis elects new MD for UK plant

October 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

October 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …
microsoft_sign_on_german_campus

Adents and Microsoft pool resources to create new cloud platform

October 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adents, EU, France, Microsoft

Adents, a French software developer for unique production identification and ‘Track & Trace’ solutions, and Microsoft have developed, with an …
aedes_aegypti_mosquito

Sanofi forms new alliance to fight zika in Brazil

October 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Zika

Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …
teva_copy

Teva team up with IBM to tackle two challenges facing the pharma industry

October 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, Teva Pharmaceutical, asthma, ibm

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …
shutterstock_359806121

Oxford Genetics gets further £1 million investment boost

October 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mercia Technologies, Oxford Genetics, synthetic biology

Warwickshire-based biotech Mercia Technologies has injected a further £1 million into synthetic biology- specialist Oxford Genetics, bringing their total investment …
cq5dam

AZ reveals compelling PhIII data for ovarian cancer treatment

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AstraZeneca, lynparza

AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …
19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …
november_2016_front_page

The November Issue of Pharmafocus is now live!

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, features, latest news, news

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …
shutterstock_57369385

NHS suppliers investigated over 1000% price hikes

October 26, 2016 Research and Development, Sales and Marketing NHS, price hikes

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …
The Gateway to Local Adoption Series

Latest content